檢索結果 - Ming–Shen Dai

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting

    Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting 由 Shaheenah Dawood, Maria Konstantionva, Rebecca Dent, Florencia Perazzo, Sung‐Bae Kim, Cynthia Villarreal‐Garza, Sandra Franco, Ming‐Shen Dai, Sérgio D. Simon

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    The Risk of Breast Cancer between Western and Mediterranean Dietary Patterns

    The Risk of Breast Cancer between Western and Mediterranean Dietary Patterns 由 Hsueh-Han Tsai, Jyh‐Cherng Yu, Huan-Ming Hsu, Chi-Hong Chu, Tzu-Ming Chang, Zhi‐Jie Hong, An‐Chieh Feng, Chun‐Yu Fu, Kuo–Feng Hsu, Ming‐Shen Dai, Guo‐Shiou Liao

    出版 2023
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression

    Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression 由 Chun-Yu Liu, Tzu‐Ting Huang, Yi‐Ting Chen, Ji-Lin Chen, Pei‐Yi Chu, Chun-Teng Huang, Wan‐Lun Wang, Ka-Yi Lau, Ming-Shen Dai, Chung-Wai Shiau, Ling‐Ming Tseng

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles

    Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles 由 Edward J. Chisholm, Georges Vassaux, Pilar Martín‐Duque, Raphaël Chèvre, Olivier Lambert, Bruno Pitard, Andrew Merron, Mark C. Willingham, Jerome Burnet, Inge Peerlinck, Ming‐Shen Dai, Ghassan Alusi, Stephen J. Mather, Katherine Bolton, Ijeoma F. Uchegbu, Andreas G. Schätzlein, Patrick Baril

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial

    Sacituzumab govitecan in HR+HER2− metastatic breast cancer: the randomized phase 3 EVER-132-002 trial 由 Binghe Xu, Shusen Wang, Min Yan, Joohyuk Sohn, Wei Li, Jin-hai Tang, Xiaojia Wang, Ying Wang, Seock‐Ah Im, Dongdong Jiang, T. Valdez, Anandaroop Dasgupta, Yiran Zhang, Yi‐Lin Yan, Kimberly M. Komatsubara, Wei‐Pang Chung, Fei Ma, Ming‐Shen Dai

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases

    Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases 由 Shih‐Wen Huang, Yein‐Gei Lai, Hao-Ting Liao, Chin-Ling Chang, Ruo-Yu Ma, Yung‐Hsiang Chen, Yae-Huei Liou, Zhenqi Wu, Yu-Chen Wu, Ko‐Jiunn Liu, Yen‐Tsung Huang, Jen-Lung Yang, Ming‐Shen Dai, Nan‐Shih Liao

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression

    Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression 由 Tzu‐Ting Huang, Ling‐Ming Tseng, Ji‐Lin Chen, Pei‐Yi Chu, Chia‐Han Lee, Chun‐Teng Huang, Wan‐Lun Wang, Ka-Yi Lau, Mei‐Fang Tseng, Yuan-Ya Chang, Tzu-Yi Chiang, Yune‐Fang Ueng, Hsin‐Chen Lee, Ming‐Shen Dai, Chunyu Liu

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial

    Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial 由 Sara A. Hurvitz, Cristina Saura, Mafalda Oliveira, Maureen Trudeau, Beverly Moy, Suzette Delaloge, William J. Gradishar, Sung‐Bae Kim, Barbara Haley, Larisa Ryvo, Ming–Shen Dai, Vladimir Milovanov, Jesús Alarcón, Sujith Kalmadi, Eduardo Cronemberger, Cristiano de Pádua Souza, Luciana Castro Garcia Landeiro, Ron Bose, Judith D. Bebchuk, Fairooz F. Kabbinavar, Richard Bryce, Kiana Keyvanjah, Adam Brufsky

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

    Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial 由 Cristina Saura, Mafalda Oliveira, Yin‐Hsun Feng, Ming‐Shen Dai, Shang-Wen Chen, Sara A. Hurvitz, Sung‐Bae Kim, Beverly Moy, Suzette Delaloge, William J. Gradishar, Norikazu Masuda, Markéta Palácová, Maureen Trudeau, Johanna Mattson, Yoon Sim Yap, Ming‐Feng Hou, Michelino De Laurentiis, Yu‐Min Yeh, Hong‐Tai Chang, Thomas Yau, Hans Wildiers, Barbara Haley, Daniele Fagnani, Yen‐Shen Lu, John Crown, Johnson Lin, Masato Takahashi, Toshimi Takano, Miki Yamaguchi, Takaaki Fujii, Bin Yao, Judith D. Bebchuk, Kiana Keyvanjah, Richard Bryce, Adam Brufsky

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2− advanced breast cancer

    Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2− advanced breast cancer 由 Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim, Yeşim Eralp, Yoon Sim Yap, Seock‐Ah Im, Julie Rihani, Erhan Gökmen, Ahmed El Bastawisy, Nuri Karadurmuş, Yueh Ni Lim, Chun Sen Lim, Le Thanh Duc, Wei‐Pang Chung, Govind Babu, Konstantin Penkov, James Bowles, T. Delgar Alfaro, Jiwen Wu, Melissa Gao, Khémaies Slimane, Nagi S. El Saghir, Adher Alsayed, Ahmed El Bastawisy, Ajay Gogia, Chaiyut Charoentum, Chanchal Goswami, Chien-Ting Liu, Chun Sen Lim, Е. В. Артамонова, Erhan Gökmen, Esat Namal, Eznal Izwadi Mohd Mahidin, Fadi Farhat, Flora Chong Li Tze, Gül Başaran, Hakan Harputluoğlu, Hamdy A. Azim, Hikmat Abdel‐Razeq, Hesham Ahmed ElGhazaly, K. Govind Babu, Konstantin Penkov, Le Thanh Duc, Ling‐Ming Tseng, Liudmila Osmanova, Lyudmila Zhukova, Meher Lakshmi Konatum, Mehmet Alı Nahıt Şendur, Ming‐Shen Dai, Mona Ayoubi, Nagi S. El Saghir, Naiyarat Prasongsook, Napa Parinyanitikul, Nikita Volkov, Nuri Karadurmuş, Patrapim Sunpaweravong, Peter Ang, Pei Jye Voon, Rabab Gaafar, Rasha Abdel Motagaly, Richard Khanyile, Sema Sezgin Göksu, Shin‐Cheh Chen, Sudeep Gupta, Su Mien Lynette Ngo, Swee Hsia Choong, Terence Aik Huang Tan, Umut Demırcı, Wei‐Pang Chung, Wen‐Son Hsieh, Yen‐Shen Lu, Yeşim Eralp, Yoon Sim Yap, Yuan‐Ching Chang, Yueh Ni Lim

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: